185 related articles for article (PubMed ID: 34163003)
21. Profiling of gastric cancer cell-surface markers to achieve tumour-normal discrimination.
Toh J; Hoppe MM; Thakur T; Yang H; Tan KT; Pang B; Ho S; Roy R; Ho KY; Yeoh KG; Tan P; Sundar R; Jeyasekharan A
BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816956
[TBL] [Abstract][Full Text] [Related]
22. A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer.
Shen Q; Polom K; Williams C; de Oliveira FMS; Guergova-Kuras M; Lisacek F; Karlsson NG; Roviello F; Kamali-Moghaddam M
EBioMedicine; 2019 Jun; 44():322-333. PubMed ID: 31151932
[TBL] [Abstract][Full Text] [Related]
23. Development of a novel gene signature in patients without Helicobacter pylori infection gastric cancer.
Lv X; Zhao Y; Zhang L; Zhou S; Zhang B; Zhang Q; Jiang L; Li X; Wu H; Zhao L; Wei M; He M
J Cell Biochem; 2020 Feb; 121(2):1842-1854. PubMed ID: 31633246
[TBL] [Abstract][Full Text] [Related]
24. Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray.
Yang L; Wang J; Li J; Zhang H; Guo S; Yan M; Zhu Z; Lan B; Ding Y; Xu M; Li W; Gu X; Qi C; Zhu H; Shao Z; Liu B; Tao SC
Mol Cell Proteomics; 2016 Feb; 15(2):614-23. PubMed ID: 26598640
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide long non-coding RNAs identified a panel of novel plasma biomarkers for gastric cancer diagnosis.
Zheng R; Liang J; Lu J; Li S; Zhang G; Wang X; Liu M; Wang W; Chu H; Tao G; Zhao Q; Wang M; Du M; Qiang F; Zhang Z
Gastric Cancer; 2019 Jul; 22(4):731-741. PubMed ID: 30603909
[TBL] [Abstract][Full Text] [Related]
26. CircRNAs as Potential Blood Biomarkers and Key Elements in Regulatory Networks in Gastric Cancer.
Reis-das-Mercês L; Vinasco-Sandoval T; Pompeu R; Ramos AC; Anaissi AKM; Demachki S; de Assumpção PP; Vidal AF; Ribeiro-Dos-Santos Â; Magalhães L
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054834
[TBL] [Abstract][Full Text] [Related]
27. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
28. Construction and Validation of a Novel Prognostic Signature for Intestinal Type of Gastric Cancer.
Zhang F; Maswikiti EP; Wei Y; Wu W; Li Y
Dis Markers; 2021; 2021():5567392. PubMed ID: 34422135
[TBL] [Abstract][Full Text] [Related]
29. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
30. CircRNA microarray profiling identifies a novel circulating biomarker for detection of gastric cancer.
Tang W; Fu K; Sun H; Rong D; Wang H; Cao H
Mol Cancer; 2018 Sep; 17(1):137. PubMed ID: 30236115
[TBL] [Abstract][Full Text] [Related]
31. A sensitive and robust plasma-based DNA methylation panel for early detection of target gastrointestinal cancers.
Dai Y; Li H; Wu Q; Wang J; Wang K; Fei S; Pei B; Song L; Chen G; Ma Y; Xia C; Xiong S; Zheng M; Xue Y; Zhao G; Xu H
Neoplasia; 2023 Dec; 46():100941. PubMed ID: 37918207
[TBL] [Abstract][Full Text] [Related]
32. A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer.
Ahadi A
Immunogenetics; 2021 Apr; 73(2):155-161. PubMed ID: 33399935
[TBL] [Abstract][Full Text] [Related]
33. Targeted plasma proteomic analysis uncovers a high-performance biomarker panel for early diagnosis of gastric cancer.
Feng T; Jie M; Deng K; Yang J; Jiang H
Clin Chim Acta; 2024 May; 558():119675. PubMed ID: 38631604
[TBL] [Abstract][Full Text] [Related]
34. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
[TBL] [Abstract][Full Text] [Related]
35. Serum PIWI-Interacting RNAs piR-020619 and piR-020450 Are Promising Novel Biomarkers for Early Detection of Colorectal Cancer.
Wang Z; Yang H; Ma D; Mu Y; Tan X; Hao Q; Feng L; Liang J; Xin W; Chen Y; Wu Y; Jia Y; Zhao H
Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):990-998. PubMed ID: 32066615
[TBL] [Abstract][Full Text] [Related]
36. Identification and verification of the molecular mechanisms and prognostic values of the cadherin gene family in gastric cancer.
Luo S; Lin R; Liao X; Li D; Qin Y
Sci Rep; 2021 Dec; 11(1):23674. PubMed ID: 34880371
[TBL] [Abstract][Full Text] [Related]
37. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
38. Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
Sun T; Wang D; Ping Y; Sang Y; Dai Y; Wang Y; Liu Z; Duan X; Tao Z; Liu W
Int J Oncol; 2020 Feb; 56(2):460-469. PubMed ID: 31894266
[TBL] [Abstract][Full Text] [Related]
39. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
40. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
